171 related articles for article (PubMed ID: 38009419)
1. Clinical and imaging predictors of late-onset GM2 gangliosidosis: A scoping review.
Godbole NP; Haxton E; Rowe OE; Locascio JJ; Schmahmann JD; Eichler FS; Ratai EM; Stephen CD
Ann Clin Transl Neurol; 2024 Jan; 11(1):207-224. PubMed ID: 38009419
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging and spectroscopy in late-onset GM2-gangliosidosis.
Rowe OE; Rangaprakash D; Weerasekera A; Godbole N; Haxton E; James PF; Stephen CD; Barry RL; Eichler FS; Ratai EM
Mol Genet Metab; 2021 Aug; 133(4):386-396. PubMed ID: 34226107
[TBL] [Abstract][Full Text] [Related]
3. Pontocerebellar atrophy is the hallmark neuroradiological finding in late-onset Tay-Sachs disease.
Májovská J; Hennig A; Nestrasil I; Schneider SA; Jahnová H; Vaněčková M; Magner M; Dušek P
Neurol Sci; 2022 May; 43(5):3273-3281. PubMed ID: 34800199
[TBL] [Abstract][Full Text] [Related]
4. Clinical, Imaging, Genetic, and Disease Course Characteristics in Patients With GM2 Gangliosidosis: Beyond Age of Onset.
Kern J; Böhringer J; Timmann D; Trollmann R; Stendel C; Kamm C; Röbl M; Santhanakumaran V; Groeschel S; Beck-Wödl S; Göricke S; Krägeloh-Mann I; Synofzik M
Neurology; 2024 Jan; 102(1):e207898. PubMed ID: 38165373
[TBL] [Abstract][Full Text] [Related]
5. The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.
Maegawa GH; Stockley T; Tropak M; Banwell B; Blaser S; Kok F; Giugliani R; Mahuran D; Clarke JT
Pediatrics; 2006 Nov; 118(5):e1550-62. PubMed ID: 17015493
[TBL] [Abstract][Full Text] [Related]
6. Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study.
Nestrasil I; Ahmed A; Utz JM; Rudser K; Whitley CB; Jarnes-Utz JR
Mol Genet Metab; 2018 Feb; 123(2):97-104. PubMed ID: 29352662
[TBL] [Abstract][Full Text] [Related]
7. Natural History of Adult Patients with GM2 Gangliosidosis.
Masingue M; Dufour L; Lenglet T; Saleille L; Goizet C; Ayrignac X; Ory-Magne F; Barth M; Lamari F; Mandia D; Caillaud C; Nadjar Y
Ann Neurol; 2020 Apr; 87(4):609-617. PubMed ID: 31995250
[TBL] [Abstract][Full Text] [Related]
8. GM2 gangliosidosis variant B1 neuroradiological findings.
Grosso S; Farnetani MA; Berardi R; Margollicci M; Galluzzi P; Vivarelli R; Morgese G; Ballestri P
J Neurol; 2003 Jan; 250(1):17-21. PubMed ID: 12527987
[TBL] [Abstract][Full Text] [Related]
9. Amyotrophy, cerebellar impairment and psychiatric disease are the main symptoms in a cohort of 14 Czech patients with the late-onset form of Tay-Sachs disease.
Jahnová H; Poupětová H; Jirečková J; Vlášková H; Košťálová E; Mazanec R; Zumrová A; Mečíř P; Mušová Z; Magner M
J Neurol; 2019 Aug; 266(8):1953-1959. PubMed ID: 31076878
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic journey for patients with late-onset GM2 Gangliosidoses.
Lopshire MC; Tifft C; Burns J; Gould R; Zheng R; Batsu I
Mol Genet Metab Rep; 2023 Dec; 37():101014. PubMed ID: 38053937
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome assessments of disease burden and progression in late-onset GM2 gangliosidoses.
Kissell J; Rochmann C; Minini P; Eichler F; Stephen CD; Lau H; Toro C; Johnston JM; Krupnick R; Hamed A; Cox GF
Mol Genet Metab; 2024 Jun; 142(3):108512. PubMed ID: 38870773
[TBL] [Abstract][Full Text] [Related]
12. A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia.
Fields T; Patterson M; Bremova-Ertl T; Belcher G; Billington I; Churchill GC; Davis W; Evans W; Flint S; Galione A; Granzer U; Greenfield J; Karl R; Kay R; Lewi D; Mathieson T; Meyer T; Pangonis D; Platt FM; Tsang L; Verburg C; Factor M; Strupp M
Trials; 2021 Jan; 22(1):84. PubMed ID: 33482890
[TBL] [Abstract][Full Text] [Related]
13. Quantitative brain morphometry identifies cerebellar, cortical, and subcortical gray and white matter atrophy in late-onset Tay-Sachs disease.
Májovská J; Nestrašil I; Ahmed A; Bondy MT; Klempíř J; Jahnová H; Schneider SA; Horáková D; Krásenský J; Ješina P; Vaneckova M; Nascene DR; Whitley CB; Jarnes JR; Magner M; Dušek P
J Inherit Metab Dis; 2024 Mar; 47(2):327-339. PubMed ID: 38112342
[TBL] [Abstract][Full Text] [Related]
14. Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases.
Lyn N; Pulikottil-Jacob R; Rochmann C; Krupnick R; Gwaltney C; Stephens N; Kissell J; Cox GF; Fischer T; Hamed A
Orphanet J Rare Dis; 2020 Apr; 15(1):92. PubMed ID: 32295606
[TBL] [Abstract][Full Text] [Related]
15. Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders.
Nagao S; Yokota O; Ikeda C; Takeda N; Ishizu H; Kuroda S; Sudo K; Terada S; Murayama S; Uchitomi Y
Eur Arch Psychiatry Clin Neurosci; 2014 Jun; 264(4):317-31. PubMed ID: 24272318
[TBL] [Abstract][Full Text] [Related]
16. Quantitative oculomotor and nonmotor assessments in late-onset GM2 gangliosidosis.
Stephen CD; Balkwill D; James P; Haxton E; Sassower K; Schmahmann JD; Eichler F; Lewis R
Neurology; 2020 Feb; 94(7):e705-e717. PubMed ID: 31964693
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics of early juvenile GM2 gangliosidosis: a case report].
Ono H; Sugiura C; Narita A; Ohno K; Saito Y; Maegaki Y; Murakami N; Nanba E
No To Hattatsu; 2017 May; 49(3):203-6. PubMed ID: 30113798
[TBL] [Abstract][Full Text] [Related]
18. Cerebellar atrophy on top of motor neuron compromise as indicator of late-onset GM2 gangliosidosis.
Hölzer HT; Boschann F; Hennermann JB; Hahn G; Hermann A; von der Hagen M; Tüngler V
J Neurol; 2021 Jun; 268(6):2259-2262. PubMed ID: 33751187
[No Abstract] [Full Text] [Related]
19. Late onset GM2 gangliosidosis mimicking spinal muscular atrophy.
Jamrozik Z; Lugowska A; Gołębiowski M; Królicki L; Mączewska J; Kuźma-Kozakiewicz M
Gene; 2013 Sep; 527(2):679-82. PubMed ID: 23820084
[TBL] [Abstract][Full Text] [Related]
20. GM2 gangliosidosis in a UK study of children with progressive neurodegeneration: 73 cases reviewed.
Smith NJ; Winstone AM; Stellitano L; Cox TM; Verity CM
Dev Med Child Neurol; 2012 Feb; 54(2):176-82. PubMed ID: 22115551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
